With WAYFIND-R, advancing precision oncology is within reach

WAYFIND-R is a global registry that will collect data from patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.

WAYFIND-R aims to enable collaborations and to provide meaningful insights and high-quality evidence to enhance our understanding of precision oncology and ultimately transform the lives of people with cancer.

WAYFIND-R_Documents_Icon.png

Learn more about WAYFIND-R

WAYFIND-R is a global, multicentre, prospective pan-cancer registry to collect long-term data to gain clinical insights on characteristics and outcomes from patients with solid tumors profiled with a next-generation sequencing (NGS) test in routine care.

 

WAYFIND-R_Researchers_Icon.png

Explore data and research opportunities

WAYFIND-R aims to provide the medical and scientific community with access to high-quality data and exciting opportunities to collaborate and help advance cancer research, all within a secure database.

 

 

WAYFIND-R_Hospitals_Icon.png

Become a participating site

WAYFIND-R is always looking to expand its community and work with new sites.  The more sites that join, the more representative the WAYFIND-R population becomes. This will improve the quality and relevance of WAYFIND-R’s data and, in addition, its research capabilities and value for patients.

The WAYFIND-R community

fit_participants_icon.svg

3150

participants

fit_countries_icon.svg

31

participating
countries

*Note that the estimated numbers are subject to change (status as of 22/Feb/2024).

 

WAYFIND-R active sites map